Stockreport

Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024

Immatics N.V. - Ordinary Shares  (IMTX) 
PDF Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active [Read more]